CCL5 and non-small cell lung carcinoma: In a longitudinal study, higher post-treatment levels of serum G-CSF and RANTES, as well as a lower level of leptin after treatment, were observed in irAE NSCLC patients, compared with non-irAE NSCLC patients (147) (Figure 2).